Mechanomyography Reloaded? A Randomized Prospective Agreement Study - Trial NCT06230653
Access comprehensive clinical trial information for NCT06230653 through Pure Global AI's free database. This phase not specified trial is sponsored by University Hospital Ulm and is currently Not yet recruiting. The study focuses on Neuromuscular Blockade. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
University Hospital Ulm
Timeline & Enrollment
N/A
Jan 22, 2024
Apr 30, 2024
Primary Outcome
Precision of the Mechanomyography
Summary
Neuromuscular monitoring is used to evaluate neuromuscular function intraoperatively and to
 ensure complete neuromuscular recovery at the end of anaesthesia. Therefore, the lack of
 reliable neuromuscular monitoring devices that are not cumbersome to use is a major
 shortcoming for anaesthesia. A recently developed mechanomyography (MMG) device may meet
 these partially unmet needs due to its measurement of the patient's contractile force instead
 of its surrogates (i.e., acceleration, velocity), including the response to physiologically
 relevant tetanic stimulation. However, it is unclear whether the reliability of the newly
 developed MMG device is similar to or better than the currently available gold standard of
 neuromuscular monitoring based on electromyography (EMG).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06230653
Non-Device Trial